Drinking Black Tea Linked to Lower Risk of Dying From CVD Drinking Black Tea Linked to Lower Risk of Dying From CVD
Drinking tea, even at higher levels and even in areas where black tea is favored, is associated with a reduced risk for death overall and from CVD, ischemic heart disease, and stroke.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Conservation Therapy Decreases Heart-Specific Mortality Breast Conservation Therapy Decreases Heart-Specific Mortality
Breast conservation therapy has been found to significantly decrease heart-specific mortality compared with mastectomy for patients with breast cancer.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nearly 30% of US Cancer Deaths Linked to Smoking Nearly 30% of US Cancer Deaths Linked to Smoking
Despite declines, cigarette smoking is associated with almost 30% of all cancer deaths in the U.S., plus billions in lost earnings.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

At-Home Test for Oral/Throat Cancer Launched in US At-Home Test for Oral/Throat Cancer Launched in US
The test is marketed directly to the general public. An expert says it has ' potential ' but is concerned about false negative and positive results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer
The new indication for pemigatinib makes it the only available targeted treatment for myeloid/lymphoid neoplasms with FGFR1 rearrangement.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Young Children With Leukemia Are Outliving Teens Young Children With Leukemia Are Outliving Teens
Leukemia survival rates are increasing, but adolescents and young adults who survive 5 years after diagnosis face an ongoing higher risk for death.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Stem Cell Transplant, CAR-T Combo May Improve Lymphoma Survival Stem Cell Transplant, CAR-T Combo May Improve Lymphoma Survival
The study only included six patients with relapsed/refractory lymphoma but suggests a synergistic effect with two therapies. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy Improves Survival by 10% Compared to Chemo Immunotherapy Improves Survival by 10% Compared to Chemo
Two new meta-analyses find that immune checkpoint inhibitors improve survival by about 10% compared with chemotherapy and do not diminish quality of life.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study Associates Hydroquinone Use With Skin Cancer Risk Study Associates Hydroquinone Use With Skin Cancer Risk
Hydroquinone, an ingredient in skin lightening agents worldwide, is linked with increased risk for skin cancer, researchers report.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Titanium Jaw Successfully 3D-Printed and Implanted Titanium Jaw Successfully 3D-Printed and Implanted
Move over, Iron Man. Titanium is next. Scientists have figured out how to replace an essential bone in the body in a strong, perfect fit. The approach is now being tested in other parts of the skull.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Problems With Drugs That Get Speedy OKs: What To Do? Problems With Drugs That Get Speedy OKs: What To Do?
Many drugs with accelerated approvals lack ' high added ' value compared with other therapies, and conducting further trials of these drugs is financially risky for the manufacturers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Include Patients With Melanoma Brain Mets in Clinical Trials? Include Patients With Melanoma Brain Mets in Clinical Trials?
The study was published on  researchsquare.com as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Cancer Brain Metastasis: Which Tool to Pick at What Time? Breast Cancer Brain Metastasis: Which Tool to Pick at What Time?
Drs Carey Anders, Steve Braunstein, Nancy Lin, and Michelle Melisko discuss the management of brain metastasis arising from breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

In Denial: When Patients Don't Want to Believe They Have Cancer In Denial: When Patients Don't Want to Believe They Have Cancer
Although not common, some oncologists say they are increasingly experiencing patient denial following a cancer diagnosis. Experts offer advice on how to handle these challenging situations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Ibrutinib Now Approved for Children With Chronic GVHD Ibrutinib Now Approved for Children With Chronic GVHD
Ibrutinib is now approved for chronic graft-vs-host disease in children aged 1 to 12 years and is available in a new oral suspension formulation.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news